{"Decreased appetite": 2.5915455189610968, "Hypertension": 4.255313693547228, "Malignant neoplasm progression": 10.076448626612216, "Palmar-plantar erythrodysaesthesia syndrome": 21.372306069844967, "Product use in unapproved indication": 4.717998904059279}